Gillian Hunter

Gillian Hunter is a Senior Lecturer in Biological and Biomedical Sciences at Glasgow Caledonian University with an ORCID ID of 0000-0002-1953-0058. She maintains an active research profile with 37 documented research outputs and an h-index of 25 based on 2304 citations. She also holds an external position as a Member of the Euan MacDonald Centre at the University of Edinburgh since August 2015.

Her educational background includes:

• First degree in Genetics from the University of Glasgow with industrial placement at AstraZeneca
• PhD from the Institute of Psychiatry, Kings College London focusing on Alzheimer's disease genetics

Dr. Hunter's research centers on neurodegenerative diseases, particularly Alzheimer's disease and Spinal Muscular Atrophy (SMA). Her work spans molecular mechanisms, genetic risk factors, and therapeutic development. Early in her career, she developed expertise in infectious bacterial artificial chromosomes (iBACs) for functional analysis of disease-associated genetic variations. Since 2011, her research has increasingly focused on SMA pathogenesis and multi-system involvement in neurodegenerative conditions.

Analysis of her publication record reveals a strong trajectory from fundamental genetic studies toward therapeutic target identification, with recent work exploring vascular components of neurological diseases and protein homeostasis pathways. Her research shows particular strength in ubiquitin-related mechanisms and cellular signaling pathways in neurodegeneration.

Her scientific recognition includes:

• Fellowship from Alzheimer's Research Trust
• Fellowship from Alzheimer's Society

Dr. Hunter has secured multiple competitive research grants including projects on:

• The role of CYTSB in spinal muscular atrophy
• Novel effectors of Nrf2 dysregulation in Alzheimer's Disease
• Histone ubiquitination in Alzheimer's disease
• Neural crest cell development in spinal muscular atrophy

Her research contributes to UN Sustainable Development Goals related to health and well-being, with particular relevance to neurological disorders and aging populations.